68 The protective effect of decaffeinated coffee suggests other compounds may also important
By Indication, Type 2 Diabetes mellitus leads the market, due to high prevalence, strong glycemic control, and clinical benefits Type 2 Diabetes Mellitus (T2DM) dominates the GLP-1 receptor agonist market, with a 61.7% share in 2025 , driven by its high global prevalence
14 The recommended starting dose depends on the background therapy the patient is taking at the time of drug initiation
Weekly formulations may improve adherence compared to daily injections for some patients
Information provided by this article DOES NOT create a practitioner/patient relationship between you and any persons affiliated with this article or website
Ideal candidates are adults in generally good health who have localized areas of stubborn fat that resist diet and exercise